Qlife Q2 2023: Cost reductions completed - Redeye

Qlife has restructured its operations, reducing its workforce considerably and terminating its leasing contract, so the fixed costs will be much lower going forward. It will focus on co-development in medical research and sales of CRP tests with partners. The financial situation is still strained, but the company has cash to continue operations during this year.

Länk till analysen i sin helhet: https://www.redeye.se/research/933385/qlife-q2-2023-cost-reductions-completed?utm_source=finwire&utm_medium=RSS